AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 290: R749-R756, 2006. First published November 3, 2005; doi:10.1152/ajpregu.00487.2005
0363-6119/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/3/R749    most recent
00487.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Briz, O.
Right arrow Articles by Marin, J. J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Briz, O.
Right arrow Articles by Marin, J. J. G.

DEVELOPMENTAL PHYSIOLOGY AND PREGNANCY

Excretion of fetal biliverdin by the rat placenta-maternal liver tandem

Oscar Briz,1 Rocio I. R. Macias,1 Maria J. Perez,2 Maria A. Serrano,3 and Jose J. G. Marin1

1Department of Physiology and Pharmacology, 2Research Unit, University Hospital, 3Department of Biochemistry and Molecular Biology, Laboratory of Experimental Hepatology and Drug Targeting, University of Salamanca, Spain

Submitted 6 July 2005 ; accepted in final form 27 October 2005

Fetal liver immaturity is accompanied by active heme catabolism. Thus fetal biliary pigments must be excreted toward the mother by the placenta. To investigate biliverdin handling by the placenta-maternal liver tandem, biliverdin-IX{alpha} was administered to 21-day pregnant rats through the jugular vein or the umbilical artery of an in situ perfused placenta. Jugular administration resulted in the secretion into maternal bile of both bilirubin and biliverdin (3:1). However, when biliverdin was administered to the placenta, most of it was transformed into bilirubin before being transferred to the maternal blood. Injecting Xenopus laevis oocytes with mRNA from rat liver or placenta enhanced their ability to take up biliverdin, which was inhibited by estradiol 17beta-D-glucuronide. The expression of three OATP isoforms in this system revealed that they have a varying degrees of ability to transport biliverdin (Oatp1/1a1 > Oatp2/1a4 > Oatp4/1b2). The abundance of their mRNA in rat trophoblast was Oatp1/1a1 >> Oatp4/1b2 > Oatp2/1a4. The expression of biliverdin-IX{alpha} reductase in rat placenta was detected by RT-PCR/sequencing and Western blot analysis. The relative abundance of biliverdin-IX{alpha} reductase mRNA (determined by real-time quantitative RT-PCR) was fetal liver > placenta > maternal liver. Common bile duct ligation in the last week of pregnancy induced an upregulation of biliverdin-IX{alpha} reductase in maternal liver but had no effect on fetal liver and placenta. In conclusion, several members of the OATP family may contribute to the uptake of fetal biliverdin by the rat placenta. Before being transferred to the mother, biliverdin is extensively converted into bilirubin by biliverdin-IX{alpha} reductase, whose expression is maintained even though bilirubin excretion into maternal bile is impaired.

bilirubin; biliary pigment; heme; pregnancy; transport



Address for reprint requests and other correspondence: J. J. G. Marin, Departamento de Fisiologia y Farmacologia, Campus Miguel de Unamuno, E.D. S-09, 37007-Salamanca, Spain (e-mail address: jjgmarin@usal.es)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.